MIT and Harvard scientists recently created engineered CAR-NK cells that hide from the immune system and more effectively ...

SHELTON, CONNECTICUT / ACCESS Newswire / October 15, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), reports that an analyst research report was published on the Company that explains ...

Experts, scholars, student representatives, and industry colleagues from universities and research institutions in multiple ...

Management will be in attendance to participate in one-on-one and group meetings during each event. Interested investors should contact their Wells Fargo and Stifel representatives, respectively, to ...

A sort of "lkala 2.0", snus is a flavored pouch of tobacco that has mass appeal to young people. Presented as an alternative ...

Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating obesity and the resulting ...

The American South is brimming with boundary-pushing talent, but these five wavemakers are reshaping the region’s visual ...

Editas Medicine Announces EDIT-401 Oral Presentation at the European Society of Gene and Cell Therapy (ESGCT) 32nd Annual Congress and Participation in Upcoming Investor Conferences ...

Youth Camp Program and Legislative bill overview: brief history of program, Senate Bill 1 and House Bill 1, 89th Legislative, Special Session, and youth camp fee changes ...

AURORA, Colo., Oct. 1, 2025 /PRNewswire/ -- RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics for major autoimmune diseases, today announced that a human ...